119 related articles for article (PubMed ID: 11457996)
1. Human antibodies isolated from plasma by affinity chromatography increase the coxsackievirus B4-induced synthesis of interferon-alpha by human peripheral blood mononuclear cells in vitro.
Chehadeh W; Bouzidi A; Alm G; Wattré P; Hober D
J Gen Virol; 2001 Aug; 82(Pt 8):1899-1907. PubMed ID: 11457996
[TBL] [Abstract][Full Text] [Related]
2. Circulating and cell-bound antibodies increase coxsackievirus B4-induced production of IFN-alpha by peripheral blood mononuclear cells from patients with type 1 diabetes.
Hober D; Chehadeh W; Weill J; Hober C; Vantyghem MC; Gronnier P; Wattré P
J Gen Virol; 2002 Sep; 83(Pt 9):2169-2176. PubMed ID: 12185270
[TBL] [Abstract][Full Text] [Related]
3. Antibody-dependent enhancement of coxsackievirus B4 infectivity of human peripheral blood mononuclear cells results in increased interferon-alpha synthesis.
Hober D; Chehadeh W; Bouzidi A; Wattré P
J Infect Dis; 2001 Nov; 184(9):1098-108. PubMed ID: 11598831
[TBL] [Abstract][Full Text] [Related]
4. Serum-dependent enhancement of coxsackievirus B4-induced production of IFNα, IL-6 and TNFα by peripheral blood mononuclear cells.
Alidjinou EK; Sané F; Engelmann I; Hober D
J Mol Biol; 2013 Dec; 425(24):5020-31. PubMed ID: 24120940
[TBL] [Abstract][Full Text] [Related]
5. Viral protein VP4 is a target of human antibodies enhancing coxsackievirus B4- and B3-induced synthesis of alpha interferon.
Chehadeh W; Lobert PE; Sauter P; Goffard A; Lucas B; Weill J; Vantyghem MC; Alm G; Pigny P; Hober D
J Virol; 2005 Nov; 79(22):13882-91. PubMed ID: 16254324
[TBL] [Abstract][Full Text] [Related]
6. Antibody-dependent enhancement and neutralization against CVB4 investigated in vitro and in silico through an agent-based model.
Morvan C; Nekoua MP; Debuysschere C; Alidjinou EK; Hober D
J Med Virol; 2024 Jan; 96(1):e29399. PubMed ID: 38235792
[TBL] [Abstract][Full Text] [Related]
7. Antibody-dependent induction of type I interferons by poliovirus in human mononuclear blood cells requires the type II fcgamma receptor (CD32).
Palmer P; Charley B; Rombaut B; Daëron M; Lebon P
Virology; 2000 Dec; 278(1):86-94. PubMed ID: 11112484
[TBL] [Abstract][Full Text] [Related]
8. Immunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetes.
Hober D; Sane F; Jaïdane H; Riedweg K; Goffard A; Desailloud R
Clin Exp Immunol; 2012 Apr; 168(1):47-51. PubMed ID: 22385236
[TBL] [Abstract][Full Text] [Related]
9. Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells.
Chehadeh W; Kerr-Conte J; Pattou F; Alm G; Lefebvre J; Wattré P; Hober D
J Virol; 2000 Nov; 74(21):10153-64. PubMed ID: 11024144
[TBL] [Abstract][Full Text] [Related]
10. A part of the VP4 capsid protein exhibited by coxsackievirus B4 E2 is the target of antibodies contained in plasma from patients with type 1 diabetes.
Sauter P; Chehadeh W; Lobert PE; Lazrek M; Goffard A; Soumillon M; Caloone D; Vantyghem MC; Weill J; Fajardy I; Alm G; Lucas B; Hober D
J Med Virol; 2008 May; 80(5):866-78. PubMed ID: 18366069
[TBL] [Abstract][Full Text] [Related]
11. Monocytes of Patients with Type 1 Diabetes Harbour Enterovirus RNA.
Alidjinou EK; Chehadeh W; Weill J; Vantyghem MC; Stuckens C; Decoster A; Hober C; Hober D
Eur J Clin Invest; 2015 Sep; 45(9):918-24. PubMed ID: 26108863
[TBL] [Abstract][Full Text] [Related]
12. Yakammaoto inhibited human coxsackievirus B4 (CVB4)-induced airway and renal tubular injuries by preventing viral attachment, internalization, and replication.
Yen MH; Lee JJ; Yeh CF; Wang KC; Chiang YW; Chiang LC; Chang JS
J Ethnopharmacol; 2014 Feb; 151(3):1056-1063. PubMed ID: 24361333
[TBL] [Abstract][Full Text] [Related]
13. Role of the capsid protein VP4 in the plasma-dependent enhancement of the Coxsackievirus B4E2-infection of human peripheral blood cells.
Sauter P; Lobert PE; Lucas B; Varela-Calvino R; Alm G; Wattre P; Hober D
Virus Res; 2007 May; 125(2):183-90. PubMed ID: 17291618
[TBL] [Abstract][Full Text] [Related]
14. Antibodies enhance the infection of phorbol-ester-differentiated human monocyte-like cells with coxsackievirus B4.
Goffard A; Alidjinou EK; Sané F; Choteau L; Bouquillon C; Caloone D; Lobert PE; Hober D
Microbes Infect; 2013 Jan; 15(1):18-27. PubMed ID: 23108316
[TBL] [Abstract][Full Text] [Related]
15. Persistence of Coxsackievirus B4 in pancreatic ductal-like cells results in cellular and viral changes.
Alidjinou EK; Engelmann I; Bossu J; Villenet C; Figeac M; Romond MB; Sané F; Hober D
Virulence; 2017 Oct; 8(7):1229-1244. PubMed ID: 28112573
[TBL] [Abstract][Full Text] [Related]
16. Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection.
Chehadeh W; Weill J; Vantyghem MC; Alm G; Lefèbvre J; Wattré P; Hober D
J Infect Dis; 2000 Jun; 181(6):1929-39. PubMed ID: 10837172
[TBL] [Abstract][Full Text] [Related]
17. Relation between T-cell responses to glutamate decarboxylase and coxsackievirus B4 in patients with insulin-dependent diabetes mellitus.
Klemetti P; Hyöty H; Roivainen M; Ilonen J; Savola K; Knip M; Akerblom HK; Vaarala O
J Clin Virol; 1999 Oct; 14(2):95-105. PubMed ID: 10588452
[TBL] [Abstract][Full Text] [Related]
18. Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG.
Båve U; Magnusson M; Eloranta ML; Perers A; Alm GV; Rönnblom L
J Immunol; 2003 Sep; 171(6):3296-302. PubMed ID: 12960360
[TBL] [Abstract][Full Text] [Related]
19. Umifenovir Epigenetically Targets the
Zhang S; Xue X; Qiao S; Jia L; Wen X; Wang Y; Wang C; Li H; Cui J
Microbiol Spectr; 2023 Feb; 11(1):e0424822. PubMed ID: 36541788
[TBL] [Abstract][Full Text] [Related]
20. RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection.
Flodström-Tullberg M; Hultcrantz M; Stotland A; Maday A; Tsai D; Fine C; Williams B; Silverman R; Sarvetnick N
J Immunol; 2005 Feb; 174(3):1171-7. PubMed ID: 15661870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
